“Different trend” in multiple primary lung cancer and intrapulmonary metastasis
Open Access
- 20 February 2015
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 20 (1) , 17
Abstract
The distinguishing of intrapulmonary metastatic tumors from multiple primary lung cancers is difficult but of great importance for the therapeutic management and prognosis of these patients. We used genomic DNA analyzed by six microsatellites (D7S1824, D15S822, D2S1363, D10S1239, D6S1056, and D22S689) with PCR to identify discordant allelic variation from 12 patients. There are five patients with multiple primary lung cancers and seven patients who were diagnosed with intrapulmonary metastases from 850 patients with primary lung cancer in our hospital. The experiments were approved by the West China Hospital Ethics committee (No. 2013 (33)) and all patients agreed to participate in the study and signed an informed consent form. In the group of metachronous lung tumor, three of five patients have different histological types and one of five patients have the same histological type which showed “contradictory trend”. The other one showed “unique trend”. In the second group (intrapulmonary metastasis lung tumor), one patient showed “contradictory trend” and the others showed “unique trend”. “Different trends” are useful in discrimination of intrapulmonary metastasis lung cancer and multiple primary lung cancer even diagnosed with the histopathological evaluation.Keywords
This publication has 34 references indexed in Scilit:
- “Unique trend” and “contradictory trend” in discrimination of primary synchronous lung cancer and metastatic lung cancerBMC Cancer, 2013
- Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer‐related proteinsCancer, 2009
- Determination of the Molecular Relationship Between Multiple Tumors Within One Patient Is of Clinical ImportanceJournal of Clinical Oncology, 2002
- The Hallmarks of CancerCell, 2000
- Mutations of the p53 tumor suppressor gene as clonal marker for multiple primary lung cancersThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Clonal Origin of Multiple Lung CancersDiagnostic Molecular Pathology, 1997
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast CancerJNCI: Journal of the National Cancer Institute, 1993
- Multiple primary lung carcinomas: Prognosis and treatmentThe Annals of Thoracic Surgery, 1991
- Surgical Treatment of Multiple Primary Lung CancersThe Thoracic and Cardiovascular Surgeon, 1989